IBER.WS

Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

IBER.WS was delisted on the 15th of February, 2023.

Back to rankings

33 hedge funds and large institutions have $1.78M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
33
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.29M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.13K
2
+$173
3
+$7

Top Sellers

1
-$134K
2
-$4K
3
-$4K
4
MF
Magnetar Financial
Illinois
-$2.22K
5
PCM
Prelude Capital Management
New York
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.51M
2
$207K
3
$16K
4
$4.47K
5
$4.06K
6
$4K
7
$3K
8
$2.67K
9
$2.65K
10
$2.18K
11
$2.1K
12
$2.08K
13
$2K
14
$2K
15
$2K
16
$1.72K
17
$1.36K
18
$1.25K
19
$1.24K
20
$1K
21
$1K
22
$1K
23
$1K
24
$978
25
$729
1
2